Eric A. Sobie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eric A. Sobie has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Yuguang Xiong
Icahn School of Medicine at Mount Sinai, New York, NY, USA
6 shared publications - Ravi Iyengar
Department of Pharmacological Sciences and Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
5 shared publications - Young-Seon Lee
Mt Sinai Sch Med, New York, NY USA
5 shared publications - Amrita Sarkar
Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA
4 shared publications Hena R. Ramay
Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1215, New York, NY 10029, USA
4 shared publications- Ka Yee Yeung
School of Engineering and Technology, University of Washington, Box 358426, Tacoma, WA 98402, USA
4 shared publications
Latest Publications
- Open Access
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1736729
Modeling the spatiotemporal properties of crosstalk between RyR-mediated and IP3R-mediated local Ca2+ release
Ryanodine receptors (RyR) and IP 3 receptors (IP 3 R) are Ca 2+ release channels expressed on the endoplasmic/sarcoplasmic reticulum (ER/SR) membrane in various cell types. Both the spatial localization and the distinct gating properties of these channels contribute to the diverse cellular functions controlled by intracellular Ca 2+ signaling. It is known that both RyR2s and IP 3 R2s are expressed on the SR membrane of ventricular cardiomyocytes and that the expression of IP 3 R2s on the SR is increased in cardiac diseases such as heart failure (HF), and evidence that Ca 2+ release through IP 3 R2s can influence RyR2-mediated Ca 2+ release in excitation-contraction coupling has been described. However, despite the suggested functional role for crosstalk between RyR2s and IP 3 R2s, especially under pathologic conditions, most previous mathematical models of cardiomyocyte Ca 2+ signaling have accounted for only RyR2s in isolation. We hypothesized that the combined effects of (1) fragmentation and dispersion of RyR2s within calcium release units (CRUs) and (2) increased expression of IP 3 R2s that occur in HF promote pro-arrhythmic Ca 2+ spark behavior, which may contribute to increased risk of arrhythmogenic Ca 2+ wave formation and incidence of ventricular arrhythmias. We built a stochastic mathematical model of local SR Ca 2+ release events—Ca 2+ sparks—that incorporates both RyR2s and IP 3 R2s. This model considers the spatial arrangement of RyR2s and IP 3 R2s relative to one another based on published immunohistochemistry studies and the arrangement of RyR2s under HF and healthy control conditions based on super-resolution microscopy data. RyR2 and IP 3 R2 gating are modeled based on single channel patch clamp studies which show that (1) RyR2 gating is stochastic and depends on local cytosolic [Ca 2+ ], JSR [Ca 2+ ], and allosteric coupling, (2) IP 3 R2 gating is stochastic and depends primarily on local cytosolic [Ca 2+ ] and [IP 3 ], and the (3) RyR2 has a larger single channel Ca 2+ current than the IP 3 R2. Our simulations show that Ca 2+ spark probability increases with increasing IP 3 R2 expression in HF CRUs and IP 3 R2 expression mitigates differences in mean duration of and mean total Ca 2+ released during Ca 2+ sparks observed in simulations in which HF is modeled as fragmentation and dispersion of RyR2s within CRUs alone. Overall, this mathematical modeling study suggests that increased IP 3 R2 expression in the context of HF may contribute to pro-arrhythmic Ca 2+ signaling via increased Ca 2+ spark frequency but may also serve a compensatory function by countering changes in Ca 2+ spark morphology that arise due to RyR2 remodeling within CRUs in HF.
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1736729
Open AccessModeling the spatiotemporal properties of crosstalk between RyR-mediated and IP3R-mediated local Ca2+ release
Ryanodine receptors (RyR) and IP 3 receptors (IP 3 R) are Ca 2+ release channels expressed on the endoplasmic/sarcoplasmic reticulum (ER/SR) membrane in various cell types. Both the spatial localization and the distinct gating properties of these channels contribute to the diverse cellular functions controlled by intracellular Ca 2+ signaling. It is known that both RyR2s and IP 3 R2s are expressed on the SR membrane of ventricular cardiomyocytes and that the expression of IP 3 R2s on the SR is increased in cardiac diseases such as heart failure (HF), and evidence that Ca 2+ release through IP 3 R2s can influence RyR2-mediated Ca 2+ release in excitation-contraction coupling has been described. However, despite the suggested functional role for crosstalk between RyR2s and IP 3 R2s, especially under pathologic conditions, most previous mathematical models of cardiomyocyte Ca 2+ signaling have accounted for only RyR2s in isolation. We hypothesized that the combined effects of (1) fragmentation and dispersion of RyR2s within calcium release units (CRUs) and (2) increased expression of IP 3 R2s that occur in HF promote pro-arrhythmic Ca 2+ spark behavior, which may contribute to increased risk of arrhythmogenic Ca 2+ wave formation and incidence of ventricular arrhythmias. We built a stochastic mathematical model of local SR Ca 2+ release events—Ca 2+ sparks—that incorporates both RyR2s and IP 3 R2s. This model considers the spatial arrangement of RyR2s and IP 3 R2s relative to one another based on published immunohistochemistry studies and the arrangement of RyR2s under HF and healthy control conditions based on super-resolution microscopy data. RyR2 and IP 3 R2 gating are modeled based on single channel patch clamp studies which show that (1) RyR2 gating is stochastic and depends on local cytosolic [Ca 2+ ], JSR [Ca 2+ ], and allosteric coupling, (2) IP 3 R2 gating is stochastic and depends primarily on local cytosolic [Ca 2+ ] and [IP 3 ], and the (3) RyR2 has a larger single channel Ca 2+ current than the IP 3 R2. Our simulations show that Ca 2+ spark probability increases with increasing IP 3 R2 expression in HF CRUs and IP 3 R2 expression mitigates differences in mean duration of and mean total Ca 2+ released during Ca 2+ sparks observed in simulations in which HF is modeled as fragmentation and dispersion of RyR2s within CRUs alone. Overall, this mathematical modeling study suggests that increased IP 3 R2 expression in the context of HF may contribute to pro-arrhythmic Ca 2+ signaling via increased Ca 2+ spark frequency but may also serve a compensatory function by countering changes in Ca 2+ spark morphology that arise due to RyR2 remodeling within CRUs in HF.
- 31 July 2025
- Published by Wiley in The Journal of Physiology
Combine the wet and dry ingredients: Mixing experimental and computational models for a deeper understanding of stem cell‐derived cardiomyocytes
Knowledge in cardiac development, heart disease and drug‐induced toxicity has steadily progressed for centuries, but the most recent decades have seen an explosion in technological advancements that have benefited cardiac research. In particular, the development of induced pluripotent stem cells (iPSCs) derived from accessible human adult tissues, as well as lineage‐specific cell cultures differentiated from these iPSCs, has led to the rapid growth of the iPSC‐derived cardiomyocyte (iPSC‐CM) as a promising in vitro model. However, major differences in iPSC‐CM phenotype have been observed across studies. This variability may be attributed to differences in cardiomyocyte differentiation protocols, maturation efficiency, or iPSC donor genetic background. While phenotypic heterogeneity is an important aspect of modelling a population as diverse as humans, it can also confound research study interpretation and reproducibility. Computational models of iPSC‐CM physiology provide a potential avenue for assessing the mechanisms behind varied phenotypes and responses without sacrificing the valuable information this heterogeneity provides. Recently, new developments in the calibration of mechanistic models have aided in the generation of patient‐ or cell line‐specific computational models, which hold potential in benchmarking iPSC‐CM preparations. In this review, we summarize recent literature on iPSC‐CM heterogeneity and computational model calibration, and we emphasize the utility of integrating computational (‘dry lab’) models with information from experimental (‘wet lab’) datasets in future iPSC‐CM studies. image
- 31 July 2025
- Published by Wiley in The Journal of Physiology
Combine the wet and dry ingredients: Mixing experimental and computational models for a deeper understanding of stem cell‐derived cardiomyocytes
Knowledge in cardiac development, heart disease and drug‐induced toxicity has steadily progressed for centuries, but the most recent decades have seen an explosion in technological advancements that have benefited cardiac research. In particular, the development of induced pluripotent stem cells (iPSCs) derived from accessible human adult tissues, as well as lineage‐specific cell cultures differentiated from these iPSCs, has led to the rapid growth of the iPSC‐derived cardiomyocyte (iPSC‐CM) as a promising in vitro model. However, major differences in iPSC‐CM phenotype have been observed across studies. This variability may be attributed to differences in cardiomyocyte differentiation protocols, maturation efficiency, or iPSC donor genetic background. While phenotypic heterogeneity is an important aspect of modelling a population as diverse as humans, it can also confound research study interpretation and reproducibility. Computational models of iPSC‐CM physiology provide a potential avenue for assessing the mechanisms behind varied phenotypes and responses without sacrificing the valuable information this heterogeneity provides. Recently, new developments in the calibration of mechanistic models have aided in the generation of patient‐ or cell line‐specific computational models, which hold potential in benchmarking iPSC‐CM preparations. In this review, we summarize recent literature on iPSC‐CM heterogeneity and computational model calibration, and we emphasize the utility of integrating computational (‘dry lab’) models with information from experimental (‘wet lab’) datasets in future iPSC‐CM studies. image
- Open Access
predicTox: An integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs
We have used drug-induced transcriptomic responses and whole-genome sequences in healthy human induced pluripotent stem cells (iPSC)-derived cardiomyocyte lines to identify cellular functional pathways and genomic variants potentially associated with the cardiotoxic effects of tyrosine kinase inhibitors (TKIs) and other cancer drugs. Here, we describe predicTox.org, an interactive website that organizes our data and its integration with knowledge from cell pathways and genomic databases. DrugTox summary cards give results of these analyses and metadata for each drug. Fields include FDA Adverse Event Reporting System (FAERS) cardiotoxicity risk scores, cell pathways, and genomic variants potentially associated with drug-induced cardiotoxicity. At a detailed level, predicTox provides ranked lists of pathway signatures that are common for cardiotoxic TKIs, up- and downregulated pathways associated with cardiotoxicity induced by specific TKIs and TKI-regulated genes mapping to those pathways. predicTox provides downloadable lists of drug-induced differentially expressed genes (DEGs) and pathways, drug-related genomic variants associated with cardiotoxicity, all with their statistical metrics, and mathematical models to simulate drug effects on heart physiology. Building on the results of our algorithm for independent reidentification of the well-known rs2229774 variant for anthracycline-induced cardiotoxicity, we describe how our data can be queried to identify potential variants associated with drug-induced cardiotoxicity by affecting a drug’s pharmacodynamics and pharmacokinetics.
Open AccesspredicTox: An integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs
We have used drug-induced transcriptomic responses and whole-genome sequences in healthy human induced pluripotent stem cells (iPSC)-derived cardiomyocyte lines to identify cellular functional pathways and genomic variants potentially associated with the cardiotoxic effects of tyrosine kinase inhibitors (TKIs) and other cancer drugs. Here, we describe predicTox.org, an interactive website that organizes our data and its integration with knowledge from cell pathways and genomic databases. DrugTox summary cards give results of these analyses and metadata for each drug. Fields include FDA Adverse Event Reporting System (FAERS) cardiotoxicity risk scores, cell pathways, and genomic variants potentially associated with drug-induced cardiotoxicity. At a detailed level, predicTox provides ranked lists of pathway signatures that are common for cardiotoxic TKIs, up- and downregulated pathways associated with cardiotoxicity induced by specific TKIs and TKI-regulated genes mapping to those pathways. predicTox provides downloadable lists of drug-induced differentially expressed genes (DEGs) and pathways, drug-related genomic variants associated with cardiotoxicity, all with their statistical metrics, and mathematical models to simulate drug effects on heart physiology. Building on the results of our algorithm for independent reidentification of the well-known rs2229774 variant for anthracycline-induced cardiotoxicity, we describe how our data can be queried to identify potential variants associated with drug-induced cardiotoxicity by affecting a drug’s pharmacodynamics and pharmacokinetics.
- Open Access
- 11 September 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (9) , e1011806
Creating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of iPSC-CM electrophysiology have been developed to help to predict cell responses, but these models individually do not capture the phenotypic variability observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate cell preparation-specific iPSC-CM electrophysiological parameters. We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that generates sufficient data for parameter calibration, we created in silico datasets by simulating various protocols applied to a population of models with known conductance variations, and then fitted parameters to those datasets. We found that calibrating to voltage and calcium transient data under 3 varied experimental conditions, including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, improved model parameter estimates and model predictions of unseen channel block responses. This observation also held when the fitted data were normalized, suggesting that normalized fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms behind variability in perturbation responses.
- 11 September 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (9) , e1011806
Open AccessCreating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of iPSC-CM electrophysiology have been developed to help to predict cell responses, but these models individually do not capture the phenotypic variability observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate cell preparation-specific iPSC-CM electrophysiological parameters. We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that generates sufficient data for parameter calibration, we created in silico datasets by simulating various protocols applied to a population of models with known conductance variations, and then fitted parameters to those datasets. We found that calibrating to voltage and calcium transient data under 3 varied experimental conditions, including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, improved model parameter estimates and model predictions of unseen channel block responses. This observation also held when the fitted data were normalized, suggesting that normalized fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms behind variability in perturbation responses.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (1) , H242-H254
Cell-to-cell heterogeneity in ion channel conductance impacts substrate vulnerability to arrhythmia
We investigate the impact of cell-to-cell heterogeneity in ion channel conductance on substrate vulnerability to arrhythmia by measuring the vulnerable window duration in computational cardiomyocyte cable models. We demonstrate a wide range of intra-cable variability in vulnerable window duration (VWD) and show how this is changed by ion channel block and coupling strength perturbations.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (1) , H242-H254
Cell-to-cell heterogeneity in ion channel conductance impacts substrate vulnerability to arrhythmia
We investigate the impact of cell-to-cell heterogeneity in ion channel conductance on substrate vulnerability to arrhythmia by measuring the vulnerable window duration in computational cardiomyocyte cable models. We demonstrate a wide range of intra-cable variability in vulnerable window duration (VWD) and show how this is changed by ion channel block and coupling strength perturbations.
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (4) , e012022
HRAS -Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia
BACKGROUND: Germline HRAS gain-of-function pathogenic variants cause Costello syndrome (CS). During early childhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmia of unknown pathogenesis. This study investigated how overactive HRAS activity triggers arrhythmogenesis in atrial-like cardiomyocytes (ACMs) derived from human-induced pluripotent stem cells bearing CS-associated HRAS variants. METHODS: HRAS Gly12 mutations were introduced into a human-induced pluripotent stem cells-ACM reporter line. Human-induced pluripotent stem cells were generated from patients with CS exhibiting tachyarrhythmia. Calcium transients and action potentials were assessed in induced pluripotent stem cell-derived ACMs. Automated patch clamping assessed funny currents. HCN inhibitors targeted pacemaker-like activity in mutant ACMs. Transcriptomic data were analyzed via differential gene expression and gene ontology. Immunoblotting evaluated protein expression associated with calcium handling and pacemaker-nodal expression. RESULTS: ACMs harboring HRAS variants displayed higher beating rates compared with healthy controls. The hyperpolarization activated cyclic nucleotide gated potassium channel inhibitor ivabradine and the Na v 1.5 blocker flecainide significantly decreased beating rates in mutant ACMs, whereas voltage-gated calcium channel 1.2 blocker verapamil attenuated their irregularity. Electrophysiological assessment revealed an increased number of pacemaker-like cells with elevated funny current densities among mutant ACMs. Mutant ACMs demonstrated elevated gene expression (ie, ISL1 , TBX3 , TBX18 ) related to intracellular calcium homeostasis, heart rate, RAS signaling, and induction of pacemaker-nodal-like transcriptional programming. Immunoblotting confirmed increased protein levels for genes of interest and suppressed MAPK (mitogen-activated protein kinase) activity in mutant ACMs. CONCLUSIONS: CS-associated gain-of-function HRAS G12 mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia. This is the first human-induced pluripotent stem cell model establishing the mechanistic basis for multifocal atrial tachycardia in CS.
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (4) , e012022
HRAS -Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia
BACKGROUND: Germline HRAS gain-of-function pathogenic variants cause Costello syndrome (CS). During early childhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmia of unknown pathogenesis. This study investigated how overactive HRAS activity triggers arrhythmogenesis in atrial-like cardiomyocytes (ACMs) derived from human-induced pluripotent stem cells bearing CS-associated HRAS variants. METHODS: HRAS Gly12 mutations were introduced into a human-induced pluripotent stem cells-ACM reporter line. Human-induced pluripotent stem cells were generated from patients with CS exhibiting tachyarrhythmia. Calcium transients and action potentials were assessed in induced pluripotent stem cell-derived ACMs. Automated patch clamping assessed funny currents. HCN inhibitors targeted pacemaker-like activity in mutant ACMs. Transcriptomic data were analyzed via differential gene expression and gene ontology. Immunoblotting evaluated protein expression associated with calcium handling and pacemaker-nodal expression. RESULTS: ACMs harboring HRAS variants displayed higher beating rates compared with healthy controls. The hyperpolarization activated cyclic nucleotide gated potassium channel inhibitor ivabradine and the Na v 1.5 blocker flecainide significantly decreased beating rates in mutant ACMs, whereas voltage-gated calcium channel 1.2 blocker verapamil attenuated their irregularity. Electrophysiological assessment revealed an increased number of pacemaker-like cells with elevated funny current densities among mutant ACMs. Mutant ACMs demonstrated elevated gene expression (ie, ISL1 , TBX3 , TBX18 ) related to intracellular calcium homeostasis, heart rate, RAS signaling, and induction of pacemaker-nodal-like transcriptional programming. Immunoblotting confirmed increased protein levels for genes of interest and suppressed MAPK (mitogen-activated protein kinase) activity in mutant ACMs. CONCLUSIONS: CS-associated gain-of-function HRAS G12 mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia. This is the first human-induced pluripotent stem cell model establishing the mechanistic basis for multifocal atrial tachycardia in CS.
- Open Access
Creating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of iPSC-CM electrophysiology have been developed to help understand the ionic underpinnings of, and to simulate, various cell responses, but these models individually do not capture the phenotypic variability observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate cell preparation-specific iPSC-CM electrophysiological parameters. We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that generates sufficient data for parameter calibration, we created simulated datasets by applying various protocols to a population of in silico cells with known conductance variations, and we fitted to those datasets. We found that calibrating models to voltage and calcium transient data under 3 varied experimental conditions, including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, improved model parameter estimates and model predictions of unseen channel block responses. This observation held regardless of whether the fitted data were normalized, suggesting that normalized fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms behind variability in perturbation responses. Author Summary: Many drug treatments or environmental factors can trigger cardiac arrhythmias, which are dangerous and often unpredictable. Human cardiomyocytes derived from donor stem cells have proven to be a promising model for studying these events, but variability in donor genetic background and cell maturation methods, as well as overall immaturity of stem cell-derived cardiomyocytes relative to the adult heart, have hindered reproducibility and reliability of these studies. Mathematical models of these cells can aid in understanding the underlying electrophysiological contributors to this variability, but determining these models’ parameters for multiple cell preparations is challenging. In this study, we tackle these limitations by developing a computational method to simultaneously estimate multiple model parameters using data from imaging-based experiments, which can be easily scaled to rapidly characterize multiple cell lines. This method can generate many personalized models of individual cell preparations, improving drug response predictions and revealing specific differences in electrophysiological properties that contribute to variability in cardiac maturity and arrhythmia susceptibility. GLOSSARY: Model/parameter calibration : tuning one or more parameters in the computational model so that the model output more closely matches experimental data Experiment/protocol optimization : the process of determining what type and amount of data is sufficient but also feasible for our model calibration goals Protocol conditions – buffer calcium, potassium, or sodium concentrations; addition or removal of stimulus; pacing rates; channel block; etc. Protocol length(?) – number of protocol conditions Protocol data type(?) –AP, CaT, or both; normalized or non-normalized data Model prediction : using the calibrated computational model to simulate response to new (unseen) conditions, drugs, or perturbations (in our case, I Kr block) Papers on independent validation/prediction Computational pipeline : the full process of iPSC-CM computational model calibration; Includes iPSC-CM data acquisition/simulation -> data processing -> parameter calibration using genetic algorithm -> validation of calibrated models on an unseen condition (i.e. evaluating model predictions)
Open AccessCreating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of iPSC-CM electrophysiology have been developed to help understand the ionic underpinnings of, and to simulate, various cell responses, but these models individually do not capture the phenotypic variability observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate cell preparation-specific iPSC-CM electrophysiological parameters. We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that generates sufficient data for parameter calibration, we created simulated datasets by applying various protocols to a population of in silico cells with known conductance variations, and we fitted to those datasets. We found that calibrating models to voltage and calcium transient data under 3 varied experimental conditions, including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, improved model parameter estimates and model predictions of unseen channel block responses. This observation held regardless of whether the fitted data were normalized, suggesting that normalized fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms behind variability in perturbation responses. Author Summary: Many drug treatments or environmental factors can trigger cardiac arrhythmias, which are dangerous and often unpredictable. Human cardiomyocytes derived from donor stem cells have proven to be a promising model for studying these events, but variability in donor genetic background and cell maturation methods, as well as overall immaturity of stem cell-derived cardiomyocytes relative to the adult heart, have hindered reproducibility and reliability of these studies. Mathematical models of these cells can aid in understanding the underlying electrophysiological contributors to this variability, but determining these models’ parameters for multiple cell preparations is challenging. In this study, we tackle these limitations by developing a computational method to simultaneously estimate multiple model parameters using data from imaging-based experiments, which can be easily scaled to rapidly characterize multiple cell lines. This method can generate many personalized models of individual cell preparations, improving drug response predictions and revealing specific differences in electrophysiological properties that contribute to variability in cardiac maturity and arrhythmia susceptibility. GLOSSARY: Model/parameter calibration : tuning one or more parameters in the computational model so that the model output more closely matches experimental data Experiment/protocol optimization : the process of determining what type and amount of data is sufficient but also feasible for our model calibration goals Protocol conditions – buffer calcium, potassium, or sodium concentrations; addition or removal of stimulus; pacing rates; channel block; etc. Protocol length(?) – number of protocol conditions Protocol data type(?) –AP, CaT, or both; normalized or non-normalized data Model prediction : using the calibrated computational model to simulate response to new (unseen) conditions, drugs, or perturbations (in our case, I Kr block) Papers on independent validation/prediction Computational pipeline : the full process of iPSC-CM computational model calibration; Includes iPSC-CM data acquisition/simulation -> data processing -> parameter calibration using genetic algorithm -> validation of calibrated models on an unseen condition (i.e. evaluating model predictions)
- Open Access
- 10 April 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14
Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
Introduction: Tyrosine kinase inhibitor drugs (TKIs) are highly effective cancer drugs, yet many TKIs are associated with various forms of cardiotoxicity. The mechanisms underlying these drug-induced adverse events remain poorly understood. We studied mechanisms of TKI-induced cardiotoxicity by integrating several complementary approaches, including comprehensive transcriptomics, mechanistic mathematical modeling, and physiological assays in cultured human cardiac myocytes.Methods: Induced pluripotent stem cells (iPSCs) from two healthy donors were differentiated into cardiac myocytes (iPSC-CMs), and cells were treated with a panel of 26 FDA-approved TKIs. Drug-induced changes in gene expression were quantified using mRNA-seq, changes in gene expression were integrated into a mechanistic mathematical model of electrophysiology and contraction, and simulation results were used to predict physiological outcomes.Results: Experimental recordings of action potentials, intracellular calcium, and contraction in iPSC-CMs demonstrated that modeling predictions were accurate, with 81% of modeling predictions across the two cell lines confirmed experimentally. Surprisingly, simulations of how TKI-treated iPSC-CMs would respond to an additional arrhythmogenic insult, namely, hypokalemia, predicted dramatic differences between cell lines in how drugs affected arrhythmia susceptibility, and these predictions were confirmed experimentally. Computational analysis revealed that differences between cell lines in the upregulation or downregulation of particular ion channels could explain how TKI-treated cells responded differently to hypokalemia.Discussion: Overall, the study identifies transcriptional mechanisms underlying cardiotoxicity caused by TKIs, and illustrates a novel approach for integrating transcriptomics with mechanistic mathematical models to generate experimentally testable, individual-specific predictions of adverse event risk.
- 10 April 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14
Open AccessPredicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
Introduction: Tyrosine kinase inhibitor drugs (TKIs) are highly effective cancer drugs, yet many TKIs are associated with various forms of cardiotoxicity. The mechanisms underlying these drug-induced adverse events remain poorly understood. We studied mechanisms of TKI-induced cardiotoxicity by integrating several complementary approaches, including comprehensive transcriptomics, mechanistic mathematical modeling, and physiological assays in cultured human cardiac myocytes.Methods: Induced pluripotent stem cells (iPSCs) from two healthy donors were differentiated into cardiac myocytes (iPSC-CMs), and cells were treated with a panel of 26 FDA-approved TKIs. Drug-induced changes in gene expression were quantified using mRNA-seq, changes in gene expression were integrated into a mechanistic mathematical model of electrophysiology and contraction, and simulation results were used to predict physiological outcomes.Results: Experimental recordings of action potentials, intracellular calcium, and contraction in iPSC-CMs demonstrated that modeling predictions were accurate, with 81% of modeling predictions across the two cell lines confirmed experimentally. Surprisingly, simulations of how TKI-treated iPSC-CMs would respond to an additional arrhythmogenic insult, namely, hypokalemia, predicted dramatic differences between cell lines in how drugs affected arrhythmia susceptibility, and these predictions were confirmed experimentally. Computational analysis revealed that differences between cell lines in the upregulation or downregulation of particular ion channels could explain how TKI-treated cells responded differently to hypokalemia.Discussion: Overall, the study identifies transcriptional mechanisms underlying cardiotoxicity caused by TKIs, and illustrates a novel approach for integrating transcriptomics with mechanistic mathematical models to generate experimentally testable, individual-specific predictions of adverse event risk.
- Open Access
- 21 November 2022
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 18 (11) , e1010098
Coupling and heterogeneity modulate pacemaking capability in healthy and diseased two-dimensional sinoatrial node tissue models
Both experimental and modeling studies have attempted to determine mechanisms by which a small anatomical region, such as the sinoatrial node (SAN), can robustly drive electrical activity in the human heart. However, despite many advances from prior research, important questions remain unanswered. This study aimed to investigate, through mathematical modeling, the roles of intercellular coupling and cellular heterogeneity in synchronization and pacemaking within the healthy and diseased SAN. In a multicellular computational model of a monolayer of either human or rabbit SAN cells, simulations revealed that heterogenous cells synchronize their discharge frequency into a unique beating rhythm across a wide range of heterogeneity and intercellular coupling values. However, an unanticipated behavior appeared under pathological conditions where perturbation of ionic currents led to reduced excitability. Under these conditions, an intermediate range of intercellular coupling (900–4000 MΩ) was beneficial to SAN automaticity, enabling a very small portion of tissue (3.4%) to drive propagation, with propagation failure occurring at both lower and higher resistances. This protective effect of intercellular coupling and heterogeneity, seen in both human and rabbit tissues, highlights the remarkable resilience of the SAN. Overall, the model presented in this work allowed insight into how spontaneous beating of the SAN tissue may be preserved in the face of perturbations that can cause individual cells to lose automaticity. The simulations suggest that certain degrees of gap junctional coupling protect the SAN from ionic perturbations that can be caused by drugs or mutations.
- 21 November 2022
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 18 (11) , e1010098
Open AccessCoupling and heterogeneity modulate pacemaking capability in healthy and diseased two-dimensional sinoatrial node tissue models
Both experimental and modeling studies have attempted to determine mechanisms by which a small anatomical region, such as the sinoatrial node (SAN), can robustly drive electrical activity in the human heart. However, despite many advances from prior research, important questions remain unanswered. This study aimed to investigate, through mathematical modeling, the roles of intercellular coupling and cellular heterogeneity in synchronization and pacemaking within the healthy and diseased SAN. In a multicellular computational model of a monolayer of either human or rabbit SAN cells, simulations revealed that heterogenous cells synchronize their discharge frequency into a unique beating rhythm across a wide range of heterogeneity and intercellular coupling values. However, an unanticipated behavior appeared under pathological conditions where perturbation of ionic currents led to reduced excitability. Under these conditions, an intermediate range of intercellular coupling (900–4000 MΩ) was beneficial to SAN automaticity, enabling a very small portion of tissue (3.4%) to drive propagation, with propagation failure occurring at both lower and higher resistances. This protective effect of intercellular coupling and heterogeneity, seen in both human and rabbit tissues, highlights the remarkable resilience of the SAN. Overall, the model presented in this work allowed insight into how spontaneous beating of the SAN tissue may be preserved in the face of perturbations that can cause individual cells to lose automaticity. The simulations suggest that certain degrees of gap junctional coupling protect the SAN from ionic perturbations that can be caused by drugs or mutations.